{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:13:54Z","timestamp":1780085634051,"version":"3.54.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["10742.01"],"award-info":[{"award-number":["10742.01"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007343","name":"University of Brescia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.nbd.2025.107018","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T21:23:27Z","timestamp":1751664207000},"page":"107018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stage"],"prefix":"10.1016","volume":"213","author":[{"given":"Silvia","family":"Zini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Musc\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Longhena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Faustini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Tobia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Borsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Spillantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Zizioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Bellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2025.107018_bb0005","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1016\/j.parkreldis.2015.09.034","article-title":"Cognitive impairment in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"22","author":"Aarsland","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.107018_bb0010","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.107018_bb0015","doi-asserted-by":"crossref","first-page":"11116","DOI":"10.1073\/pnas.1903054116","article-title":"Synapsins regulate alpha-synuclein functions","volume":"116","author":"Atias","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.107018_bb0020","article-title":"Regular care and maintenance of a zebrafish (Danio rerio) laboratory: an introduction","volume":"e4196","author":"Avdesh","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.nbd.2025.107018_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13725","article-title":"Vesicular monoamine transporter 2 (SLC18A2) regulates monoamine turnover and brain development in zebrafish","volume":"234","author":"Baronio","year":"2022","journal-title":"Acta Physiol (Oxford)"},{"key":"10.1016\/j.nbd.2025.107018_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines7010023","article-title":"Zebrafish larvae as a behavioral model in neuropharmacology","volume":"7","author":"Basnet","year":"2019","journal-title":"Biomedicines"},{"key":"10.1016\/j.nbd.2025.107018_bb0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainres.2012.04.014","article-title":"From alpha-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson\u2019s disease","volume":"1476","author":"Bellucci","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2025.107018_bb0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/nan.12297","article-title":"Review: Parkinson\u2019s disease: from synaptic loss to connectome dysfunction","volume":"42","author":"Bellucci","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2025.107018_bb0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fnagi.2017.00330","article-title":"The end is the beginning: Parkinson\u2019s disease in the light of brain imaging","volume":"9","author":"Bellucci","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2025.107018_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0076-6879(08)03612-4","article-title":"Monitoring autophagic degradation of p62\/SQSTM1","volume":"452","author":"Bjorkoy","year":"2009","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.nbd.2025.107018_bb0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.107018_bb0060","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1242\/jeb.003939","article-title":"Modulation of locomotor activity in larval zebrafish during light adaptation","volume":"210","author":"Burgess","year":"2007","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.nbd.2025.107018_bb0065","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2025.107018_bb0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00418-009-0619-8","article-title":"Complementary developmental expression of the two tyrosine hydroxylase transcripts in zebrafish","volume":"132","author":"Chen","year":"2009","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.nbd.2025.107018_bb0075","first-page":"20120462","article-title":"Zebrafish forebrain and temporal conditioning","volume":"369","author":"Cheng","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.nbd.2025.107018_bb0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s42826-021-00103-2","article-title":"Transgenic fluorescent zebrafish lines that have revolutionized biomedical research","volume":"37","author":"Choe","year":"2021","journal-title":"Lab Anim Res"},{"key":"10.1016\/j.nbd.2025.107018_bb0085","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/mds.22833","article-title":"Anxiety disorders in Parkinson\u2019s disease: prevalence and risk factors","volume":"25","author":"Dissanayaka","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107018_bb0090","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/mdc3.13852","article-title":"Characterization of SNCA multiplication in Parkinson\u2019s disease: 2 new cases and evaluation of the literature","volume":"10","author":"Duan","year":"2023","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.nbd.2025.107018_bb0095","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/cne.24508","article-title":"Features of the structure, development, and activity of the zebrafish noradrenergic system explored in new CRISPR transgenic lines","volume":"526","author":"Farrar","year":"2018","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2025.107018_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104789","article-title":"Alpha-synuclein\/synapsin III pathological interplay boosts the motor response to methylphenidate","volume":"138","author":"Faustini","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.107018_bb0105","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.ymthe.2022.01.021","article-title":"Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson\u2019s disease-like phenotype","volume":"30","author":"Faustini","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2025.107018_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233902","article-title":"Synapsin III regulates dopaminergic neuron development in vertebrates","volume":"11","author":"Faustini","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2025.107018_bb0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40478-023-01711-w","article-title":"Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"12","author":"Frigerio","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2025.107018_bb0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuroscience.2014.09.015","article-title":"Differential expression of synapsin genes during early zebrafish development","volume":"280","author":"Garbarino","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2025.107018_bb0125","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/brain\/awq132","article-title":"SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease","volume":"133","author":"Garcia-Reitbock","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107018_bb0130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109617119","article-title":"Alpha-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity","volume":"119","author":"Ghanem","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.107018_bb0135","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00438-014-0889-2","article-title":"Whole-genome duplication in teleost fishes and its evolutionary consequences","volume":"289","author":"Glasauer","year":"2014","journal-title":"Mol. Gen. Genomics."},{"key":"10.1016\/j.nbd.2025.107018_bb0140","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1517\/17460440902988464","article-title":"Using zebrafish to assess the impact of drugs on neural development and function","volume":"4","author":"Guo","year":"2009","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.nbd.2025.107018_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105687","article-title":"The roles of connectivity and neuronal phenotype in determining the pattern of alpha-synuclein pathology in Parkinson\u2019s disease","volume":"168","author":"Henderson","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.107018_bb0150","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1152\/jn.00576.2003","article-title":"Imaging neuronal activity during zebrafish behavior with a genetically encoded calcium indicator","volume":"90","author":"Higashijima","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2025.107018_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.20278","article-title":"Distribution of prospective glutamatergic, glycinergic, and GABAergic neurons in embryonic and larval zebrafish","volume":"480","author":"Higashijima","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2025.107018_bb0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fneur.2018.00103","article-title":"Centrality of early Synaptopathy in Parkinson\u2019s disease","volume":"9","author":"Imbriani","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2025.107018_bb0165","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/cne.22214","article-title":"Genetic dissection of dopaminergic and noradrenergic contributions to catecholaminergic tracts in early larval zebrafish","volume":"518","author":"Kastenhuber","year":"2010","journal-title":"J. Comp. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2025.107018_bb0170","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/gb-2007-8-s1-s7","article-title":"Tol2: a versatile gene transfer vector in vertebrates","volume":"8","author":"Kawakami","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/j.nbd.2025.107018_bb0175","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1080\/15548627.2019.1580511","article-title":"A novel transgenic zebrafish line allows for in vivo quantification of autophagic activity in neurons","volume":"15","author":"Khuansuwan","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.nbd.2025.107018_bb0180","doi-asserted-by":"crossref","first-page":"9762","DOI":"10.1523\/JNEUROSCI.2071-09.2010","article-title":"Synapsins differentially control dopamine and serotonin release","volume":"30","author":"Kile","year":"2010","journal-title":"J. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2025.107018_bb0185","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.parkreldis.2015.09.007","article-title":"Autosomal dominant Parkinson\u2019s disease caused by SNCA duplications","volume":"22","author":"Konno","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.107018_bb0190","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","article-title":"Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies","volume":"27","author":"Kramer","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.107018_bb0195","doi-asserted-by":"crossref","first-page":"fcac165","DOI":"10.1093\/braincomms\/fcac165","article-title":"Linking alpha-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson's disease","volume":"4","author":"Kulkarni","year":"2022","journal-title":"Brain Commun"},{"key":"10.1016\/j.nbd.2025.107018_bb0200","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/bpa.12587","article-title":"Synapsin III is a key component of alpha-synuclein fibrils in Lewy bodies of PD brains","volume":"28","author":"Longhena","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2025.107018_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010141","article-title":"Living in promiscuity: the multiple Partners of Alpha-Synuclein at the synapse in physiology and pathology","volume":"20","author":"Longhena","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107018_bb0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neubiorev.2021.08.011","article-title":"An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders","volume":"130","author":"Longhena","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2025.107018_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/genes13050868","article-title":"A new zebrafish model to measure neuronal alpha-Synuclein clearance in vivo","volume":"13","author":"Lopez","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.nbd.2025.107018_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.107995","article-title":"Experimental arena size alters larval zebrafish photolocomotor behaviors and influences bioactivity responses to a model neurostimulant","volume":"177","author":"Lovin","year":"2023","journal-title":"Environ. Int."},{"key":"10.1016\/j.nbd.2025.107018_bb0225","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1074\/jbc.M111.308312","article-title":"Hypokinesia and reduced dopamine levels in zebrafish lacking beta- and gamma1-synucleins","volume":"287","author":"Milanese","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.107018_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114781","article-title":"Young human alpha synuclein transgenic (BAC-SNCA) mice display sex- and gene-dose-dependent phenotypic disturbances","volume":"460","author":"Moceri","year":"2024","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2025.107018_bb0235","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41419-019-1702-2","article-title":"Perturbation of synapsins homeostasis through HIV-1 tat-mediated suppression of BAG3 in primary neuronal cells","volume":"10","author":"Mohseni Ahooyi","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2025.107018_bb0240","series-title":"Atlas of Early Zebrafish Brain Development (Second Edition). pp. ix-x","article-title":"Preface 2015","author":"Mueller","year":"2016"},{"key":"10.1016\/j.nbd.2025.107018_bb0245","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.107018_bb0250","first-page":"571","article-title":"Axon degeneration and PGC-1alpha-mediated protection in a zebrafish model of alpha-synuclein toxicity","volume":"7","author":"O\u2019Donnell","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.nbd.2025.107018_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120660","article-title":"Degeneration of nigrostriatal dopaminergic neurons in the early to intermediate stage of dementia with Lewy bodies and Parkinson\u2019s disease","volume":"449","author":"Okitsu","year":"2023","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2025.107018_bb0260","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/mds.28387","article-title":"From iPS cells to rodents and nonhuman Primates: filling gaps in modeling Parkinson\u2019s disease","volume":"36","author":"Outeiro","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107018_bb0265","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/jnc.15174","article-title":"Distinct alpha-Synuclein species induced by seeding are selectively cleared by the lysosome or the proteasome in neuronally differentiated SH-SY5Y cells","volume":"156","author":"Pantazopoulou","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.107018_bb0270","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/dbio.2000.9898","article-title":"Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons","volume":"227","author":"Park","year":"2000","journal-title":"Dev. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2025.107018_bb0275","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"22","author":"Pfeiffer","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.107018_bb0280","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.nbd.2025.107018_bb0285","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s13311-012-0105-1","article-title":"A novel \"molecular tweezer\" inhibitor of alpha-synuclein neurotoxicity in vitro and in vivo","volume":"9","author":"Prabhudesai","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2025.107018_bb0290","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2011.08.039","article-title":"Anxiety in Parkinson's disease: a critical review of experimental and clinical studies","volume":"62","author":"Prediger","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2025.107018_bb0295","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.parkreldis.2013.01.020","article-title":"Monogenic Parkinson\u2019s disease and parkinsonism: clinical phenotypes and frequencies of known mutations","volume":"19","author":"Puschmann","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.107018_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.655550","article-title":"The promise of the zebrafish model for Parkinson\u2019s disease: today\u2019s science and tomorrow\u2019s treatment","volume":"12","author":"Razali","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.nbd.2025.107018_bb0305","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systematic review of prevalence studies of depression in Parkinson\u2019s disease","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107018_bb0310","doi-asserted-by":"crossref","first-page":"22451","DOI":"10.1074\/jbc.M113.485227","article-title":"Zebrafish tyrosine hydroxylase 2 gene encodes tryptophan hydroxylase","volume":"288","author":"Ren","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.107018_bb0315","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0006-8993(00)03174-7","article-title":"The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum)","volume":"889","author":"Rink","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2025.107018_bb0320","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0361-9230(01)00696-7","article-title":"Connections of the ventral telencephalon and tyrosine hydroxylase distribution in the zebrafish brain (Danio rerio) lead to identification of an ascending dopaminergic system in a teleost","volume":"57","author":"Rink","year":"2002","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2025.107018_bb0325","article-title":"Zebrafish embryos as in vivo test tubes to unravel cell-specific mechanisms of neurogenesis during neurodevelopment and in diseases","volume":"3","author":"Samarut","year":"2016","journal-title":"Neurogenesis (Austin)"},{"key":"10.1016\/j.nbd.2025.107018_bb0330","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/dneu.20911","article-title":"Dopaminergic and noradrenergic circuit development in zebrafish","volume":"72","author":"Schweitzer","year":"2012","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.nbd.2025.107018_bb0335","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13024-024-00765-1","article-title":"Correction: network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer\u2019s disease","volume":"19","author":"Shantaraman","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.107018_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.nbd.2025.107018_bb0345","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.107018_bb0350","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1523\/JNEUROSCI.2581-13.2014","article-title":"Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson\u2019s disease","volume":"34","author":"Spinelli","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.107018_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100372","article-title":"Detection of pathological alpha-synuclein aggregates in human iPSC-derived neurons and tissue","volume":"2","author":"Stojkovska","year":"2021","journal-title":"STAR Protoc"},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2025.107018_bb0360","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson\u2019s disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.107018_bb0365","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","article-title":"LC3 and autophagy","volume":"445","author":"Tanida","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.nbd.2025.107018_bb0370","article-title":"Using the Tg(nrd:egfp)\/albino zebrafish line to characterize in vivo expression of neurod","volume":"7","author":"Thomas","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.107018_bb0375","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41531-023-00533-w","article-title":"Defining the causes of sporadic Parkinson's disease in the global Parkinson's genetics program (GP2)","volume":"9","author":"Towns","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.nbd.2025.107018_bb0380","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/s41467-021-22108-0","article-title":"In situ architecture of neuronal alpha-Synuclein inclusions","volume":"12","author":"Trinkaus","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.107018_bb0385","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/zeb.2007.0508","article-title":"A rapid apoptosis assay measuring relative acridine orange fluorescence in zebrafish embryos","volume":"4","author":"Tucker","year":"2007","journal-title":"Zebrafish"},{"key":"10.1016\/j.nbd.2025.107018_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101695","article-title":"Alpha-Synuclein amplifies cytoplasmic peroxide flux and oxidative stress provoked by mitochondrial inhibitors in CNS dopaminergic neurons in vivo","volume":"37","author":"Van Laar","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.nbd.2025.107018_bb0395","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ymeth.2014.12.004","article-title":"Autophagy in zebrafish","volume":"75","author":"Varga","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.nbd.2025.107018_bb0400","doi-asserted-by":"crossref","first-page":"121ra120","DOI":"10.1126\/scitranslmed.3002566","article-title":"Phosphorylated alpha-synuclein in Parkinson\u2019s disease","volume":"4","author":"Wang","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2025.107018_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21175981","article-title":"Chemical and genetic zebrafish models to define mechanisms of and treatments for dopaminergic neurodegeneration","volume":"21","author":"Wasel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107018_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105291","article-title":"In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129","volume":"152","author":"Weston","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.107018_bb0415","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/dvdy.22742","article-title":"Transgenic zebrafish expressing green fluorescent protein in dopaminergic neurons of the ventral diencephalon","volume":"240","author":"Xi","year":"2011","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.nbd.2025.107018_bb0420","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mds.26477","article-title":"Autophagy and alpha-Synuclein: relevance to Parkinson\u2019s disease and related Synucleopathies","volume":"31","author":"Xilouri","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107018_bb0425","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1242\/jcs.157867","article-title":"Alpha-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons","volume":"128","author":"Zaltieri","year":"2015","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.nbd.2025.107018_bb0430","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/mdc3.13168","article-title":"Incidence and progression of rapid eye movement behavior disorder in early Parkinson\u2019s disease","volume":"8","author":"Zimansky","year":"2021","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.nbd.2025.107018_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020445","article-title":"Development of BCR-ABL1 transgenic zebrafish model reproducing chronic myeloid leukemia (CML) like-disease and providing a new insight into CML mechanisms","volume":"10","author":"Zizioli","year":"2021","journal-title":"Cells"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T20:49:49Z","timestamp":1758833389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125002347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":87,"alternative-id":["S0969996125002347"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107018","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stage","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107018"}}